Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023

SELL
$218.65 - $271.46 $114,135 - $141,702
-522 Reduced 1.09%
47,230 $12.7 Billion
Q2 2023

Jul 12, 2023

SELL
$214.27 - $253.37 $149,560 - $176,852
-698 Reduced 1.44%
47,752 $10.6 Billion
Q4 2022

Feb 06, 2023

BUY
$229.03 - $291.01 $11.1 Million - $14.1 Million
48,450 New
48,450 $12.8 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Y.D. More Investments LTD Portfolio

Follow Y.D. More Investments LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y.D. More Investments LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y.D. More Investments LTD with notifications on news.